Anti-human Respiratory Syncytial Virus (RSV) antibodies and methods of use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9988437
APP PUB NO 20160194383A1
SERIAL NO

15077558

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Provided herein are antibodies or antigen-binding fragments thereof that immunospecifically bind to the fusion (F) protein of Respiratory Syncytial Virus (RSV). Also provided are methods for of prevention, treatment and diagnosis of viral infection and/or the treatment of one more symptoms of RSV-mediated disease. Methods of generating antibodies that immunospecifically bind RSV F protein also are provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • JANSSEN VACCINES & PREVENTION B.V.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Keogh, Elissa San Diego, US 12 224
Pascual, Gabriel San Diego, US 14 152
Wadia, Jehangir San Diego, US 17 241
Williamson, Robert Anthony London, GB 17 219

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 5, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 5, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00